Thus, TUG1 promotes tumor growth and angiogenesis in HB by preventing miR-34a-5p from regulating VEGFA, which can cause TUG1 to be a possible therapeutic target for HB [13]. This evidence concerns the gene VEGFA and hemoglobin measurement.